Serratia fonticola and its role as a single pathogen causing emphysematous pyelonephritis in a non-diabetic patient: A case report

BACKGROUND Diagnosis of emphysematous pyelonephritis has been described around the world for some decades, frequently associated with Escherichia coli and other anaerobic, gas-forming bacteria and mostly in patients living with diabetes. We present a case report of emphysematous pyelonephritis in a non-diabetic patient caused by Serratia fonticola as well as a brief literature review to draw attention to this rare pathogen as a cause of pyelonephritis. CASE SUMMARY A 38-year-old female presented with fever, severe pain in the right flank and changes in urinary habits. She was admitted, and emphysematous pyelonephritis was confirmed by an abdominal computerized tomography and urine cultures; the latter showed Serratia fonticola as a single pathogen. After 3 d of being treated with piperacillin/tazobactam and percutaneous drainage she became afebrile, and the gas presence reduced. CONCLUSION Emphysematous pyelonephritis infections in non-diabetic patients are rare but can be severe and life-threatening. This case suggests that Serratia fonticola infection can occur in patients undergoing invasive or instrumented procedures.

[1]  R. Desai,et al.  A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis , 2022, International Urology and Nephrology.

[2]  C. Fan,et al.  Insulin Downregulated the Infection of Uropathogenic Escherichia coli (UPEC) in Bladder Cells in a High-Glucose Environment through JAK/STAT Signaling Pathway , 2021, Microorganisms.

[3]  Tauseef Nabi,et al.  A Prospective study of Emphysematous Pyelonephritis in Patients with Type 2 Diabetes , 2021, Indian journal of nephrology.

[4]  Yifan Huang,et al.  Establishment of a duplex real-time qPCR method for detection of Salmonella spp. and Serratia fonticola in fishmeal , 2020, AMB Express.

[5]  A. Katib,et al.  Serratia Fonticola microbe presented as a community-acquired urinary tract infection (UTI): a case report , 2020 .

[6]  N. Wani,et al.  Comparative study of emphysematous pyelonephritis and pyelonephritis in type 2 diabetes: a single-centre experience , 2020, Journal of Diabetes & Metabolic Disorders.

[7]  P. D. Hai,et al.  First report of biliary tract infection caused by multidrug-resistant Serratia fonticola , 2020, New microbes and new infections.

[8]  A. Spaulding,et al.  Epidemiology of Serratia Bloodstream Infections Among Hospitalized Children in the United States, 2009–2016 , 2020, The Pediatric infectious disease journal.

[9]  C. Stief,et al.  Emphysematous pyelonephritis: Case report and literature overview , 2018, Urologia.

[10]  Mahesh Kumar,et al.  Emphysematous Pyelonephritis Case Series From South India , 2017, Kidney international reports.

[11]  D. Pal,et al.  Double J stenting: A rewarding option in the management of emphysematous pyelonephritis , 2016, Urology annals.

[12]  R. Jump,et al.  Serratia fonticola, pathogen or bystander? A case series and review of the literature , 2016, IDCases.

[13]  A. M. de Roda Husman,et al.  Prevalence and characterization of ESBL- and AmpC-producing Enterobacteriaceae on retail vegetables. , 2015, International journal of food microbiology.

[14]  Chao-yuan Huang,et al.  Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis , 2014, BMC Infectious Diseases.

[15]  C. Chao,et al.  Emphysematous pyelonephritis. , 2012, The American journal of the medical sciences.

[16]  M. Falagas,et al.  Serratia infections in a general hospital: characteristics and outcomes , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[17]  G. Nabi,et al.  Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. , 2008, The Journal of urology.

[18]  M. Falagas,et al.  Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. , 2007, The Journal of urology.

[19]  Ahmad Khan,et al.  Successful medical management of recurrent emphysematous pyelonephritis. , 2006, Urology.

[20]  J. Wu,et al.  Host and bacterial virulence factors predisposing to emphysematous pyelonephritis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  E. Goldstein,et al.  Bacteriology of a Bear Bite Wound to a Human: Case Report , 2004, Journal of Clinical Microbiology.

[22]  P. de Micco,et al.  Serratia fonticola isolated from a leg abscess , 1991, Journal of clinical microbiology.

[23]  A. Steigerwalt,et al.  Isolation of Serratia fonticola from birds. , 1986, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

[24]  J J Farmer,et al.  Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens , 1985, Journal of clinical microbiology.

[25]  F. Gavini,et al.  Serratia fonticola, a New Species from Water , 1979 .